Evaluating Cardiovascular Benefit of Sotagliflozin Across Kidney and Cardiovascular Risk in Type 1 Diabetes: Modeling Analysis of the inTandem1–3 Trials

Diabetes Obesity and Cardiometabolic CARE 2026 Open access

Read full text
Authors: Luxcia Kugathasan, Vikas S. Sridhar, Michael J. Davies, Manon Girard, Belinda Hardin, David J.T. Campbell, Anita T. Layton, Bruce A. Perkins, Sean J. Barbour, Tony K.T. Lam, Adeera Levin, Leif Erik Lovblom
+11 more Istvan Mucsi, RÉMI P.R. RABASA-LHORET, Valeria E. Rac, Peter Alexander Senior, Ronald Jeremy Sigal, Aleksandra Vukobradovic, Frederik Persson, ELISABETH BUUR STOUGAARD, Alessandro Doria, David Z.I. Cherney, Massimo Nardone
DOI: 10.2337/doc25-0028
Cited by: 0
References: 4

Fields of Study & Subjects

Diabetes Treatment and Management Diabetes Management and Research Chronic Kidney Disease and Diabetes

Publication details

Journal / source
Diabetes Obesity and Cardiometabolic CARE
Volume
1
Issue
2
Pages
e1–e3
Publication date
1 March 2026
Language
EN